Revolution has set itself a mission to revolutionize treatment for patients with RAS addicted cancers. See why I upgrade RVMD ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Revolution Medicines (RVMD – Research ...

Revolution Medicines (RVMD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Benjamin ...

The FDA last week announced that it is looking into the safety of bluebird bio ’s gene therapy Skysona (elivaldogene ...

Dysregulated cell signaling underlies various diseases, emphasizing the importance of understanding these pathways for ...

Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today announced ...

Detailed price information for Immuneering Corp Cl A (IMRX-Q) from The Globe and Mail including charting and trades.

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that ...

Seventeen-year-old Raghav Gulati, from Dubai Creek Resort, marked a major achievement in his golfing career when he clinched ...

Oscar Craig (Jumeirah Golf Estates) may not have been at his best, but still did enough to take the lead in the Overall ...

Rami Samawi (The Els Club, Dubai) shot a first-round three under par 69 to lead the Overall Division of the Tommy Fleetwood ...

The firm will track the activity of the triplet broadly in AML patients, including in those with FLT3, NRAS, and TP53 mutations.